Wordt geladen...
Objective cerebrospinal fluid response to intraventricular rituximab in indolent CNS lymphoma
Indolent CNS lymphomas (CNSLs) are rare and no guidelines exist for management. Recent literature highlights the potential for safe and tolerable intrathecal (IT) delivery of rituximab, a large anti-CD20 monoclonal antibody, for aggressive CNSL. We report a patient with relapsed indolent CNSL who fa...
Bewaard in:
| Gepubliceerd in: | CNS Oncol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Future Medicine Ltd
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4778415/ https://ncbi.nlm.nih.gov/pubmed/25905905 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns.15.3 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|